设备检测的亚临床心房颤动持续时间与卒中发生风险:ASSERT研究
ASSERT研究纳入2580例无房颤史的起搏器或ICD患者,分析亚临床心房颤动(SCAF)持续时间与缺血性卒中或系统性栓塞风险的关系。平均随访2.5年,最长SCAF单次发作超过24小时与后续卒中或系统性栓塞风险显著增加相关(校正HR 3.24,95%CI 1.51-6.95,P=0.003);而SCAF持续时间在6分钟至24小时之间的患者风险与无SCAF患者无显著差异。
要点
- 最长SCAF单次发作超过24小时与后续卒中或系统性栓塞风险显著增加相关(校正HR 3.24)。
- SCAF持续时间在6分钟至24小时之间的患者,卒中或系统性栓塞风险与无SCAF患者无显著差异。
- 在无房颤史的起搏器或ICD患者中,SCAF持续时间超过24小时具有预后意义。
核心结论
- SCAF持续时间超过24小时与缺血性卒中或系统性栓塞风险增加相关。
研究设计与样本
- ASSERT研究随访2580例接受起搏器或ICD治疗、年龄>65岁、合并高血压且无房颤史的患者。
- 采用时间依赖协变量Cox模型评估SCAF持续时间对后续缺血性卒中或栓塞风险的影响。
- 最长SCAF≤6分钟的患者被排除分析(n=125),最终分析2455例患者。
主要发现
- 平均随访2.5年,最长单次SCAF发作>6分钟至6小时者462例(18.8%),>6-24小时者169例(6.9%),>24小时者262例(10.7%)。
- SCAF持续时间>24小时与后续卒中或系统性栓塞风险显著增加相关(校正HR 3.24,95%CI 1.51-6.95,P=0.003)。
- SCAF持续时间在6分钟至24小时之间的患者,缺血性卒中或系统性栓塞风险与无SCAF患者无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: ASSERT demonstrated that subclinical atrial fibrillation (SCAF) is common in pacemaker patients without prior AF and is associated with increased risk of ischemic stroke or systemic embolism. SCAF episodes vary in duration and little is known about the incidence of different durations of SCAF, or their prognosis. METHODS AND RESULTS: ASSERT followed 2580 patients receiving a pacemaker or ICD, aged >65 years with hypertension, without prior AF. The effect of SCAF duration on subsequent risk of ischemic stroke or embolism was evaluated with time-dependent covariate Cox models. Patients in whom the longest SCAF was ≤6 min were excluded from the analysis (n=125). Among 2455 patients during mean follow-up of 2.5 years, the longest single episode of SCAF lasted >6 min to 6 h in 462 patients (18.8%), >6-24 h in 169 (6.9%), and >24 h in 262 (10.7%). SCAF duration >24 h was associated with a significant increased risk of subsequent stroke or systemic embolism (adjusted hazard ratio [HR] 3.24, 95% confidence interval [CI] 1.51-6.95, P=0.003). The risk of ischemic stroke or systemic embolism in patients with SCAF between 6 min and 24 h was not significantly different from patients without SCAF. CONCLUSIONS: SCAF >24 h is associated with an increased risk of ischemic stroke or systemic embolism.
引用
- Van Gelder IC, Healey JS, Crijns HJGM, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017. PMID: 28329139. doi:10.1093/eurheartj/ehx042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。